News
What we are doing right now
What are we doing right now
News
Media
What are we doing right now
News
Media
What we are doing right now
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| ip2location_redirection_first_visit | session | Mostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language |
| PHPSESSID | session | Identificador de sesión PHP / PHP session id |
| prescriptionModalAccepted | session | Identificador de sesión PHP / PHP session id |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| wpml_browser_redirect_test | session | Mostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language |
| _icl_visitor_lang_js | session | Mostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language |
| Cookie | Duration | Description |
|---|---|---|
| _ga | 2 years | Google Analytics |
| _gat_gtag_UA_112188601_1 | 2 years | Google Analytics |
| _gid | 2 years | Google Analytics |
Salvat becomes the first Spanish pharmaceutical company to receive FDA approval for sterile drug manufacturing using BFS technology
/in Salvat International, Salvat Spain, Salvat USA /by Carme LopezThe pharmaceutical company Salvat has received FDA approval to manufacture Otovel, an ear drop solution for the treatment of acute otitis media, at its Pharmaloop facility in Alcalá de Henares for distribution in the U.S. market. In addition to Otovel, Salvat is expected to produce three more products from its otolaryngology and ophthalmology lines for […]
The Secretary General for Industry visits the Pharmaloop plant
/in Salvat Foundation, Salvat International, Salvat Spain /by Carme LopezMr. Raúl Blanco, Secretary General for Industry and Small and Medium Enterprises, visited Pharmaloop’s new sterile liquids plant, located in Alcalá de Henares (Madrid). Pharmaloop is the first fully autonomous pharmaceutical production center in Spain, with a natural gas cogeneration system that creates its own energy. The visit served to reinforce the company’s commitment to […]
Salvat’s Pharmaloop Invests 65 million Euros in Its New Sterile Liquids Plant, located in Alcalá de Henares
/in Salvat International, Salvat Spain, Salvat USA /by Carme LopezThe Minister of Industry, Reyes Maroto, visited Salvat’s new facility today, accompanied by the Mayor of Alcalá de Henares, Javier Rodriguez Palacios and Salvat CEO, Alberto Bueno The new 8,500 m² plant is equipped with the most advanced technology, highest quality standards and the capacity to produce more than 350 million units of sterile formulations […]
Salvat Laboratories enters in the chinese market with Cetraxal Plus Clinical Trial
/in Salvat International, Salvat Spain, Salvat USA /by Carme LopezSalvat has an agreement with Lee’s Pharmaceuticals to distribute Cetraxal® Plus in China Cetraxal® Plus is the only pharmaceutical product in the world that is available in single-dose vials for external otitis and otitis media. It was launched in 2002 in Spain and is already exported to more than 50 countries The Phase III clinical […]
Cristalmina increases production sevenfold and prepares to launch in international market
/in Salvat International, Salvat Spain, Salvat USA /by Carme LopezA new automated robotic line costing more than €6 million has enabled Cristalmina to increase production from 2.5 million to 15 million units per year By 2021, the company plans to have authorisation to market Cristalmina in more than 26 European countries, which will be followed by Asia and the USA in the years to […]